Iezzi, A., Caiola, E., & Broggini, M. (2016). Activity of Pan-Class I Isoform PI3K/mTOR Inhibitor PF-05212384 in Combination with Crizotinib in Ovarian Cancer Xenografts and PDX(). Transl Oncol.
Styl cytowania ChicagoIezzi, Alice, Elisa Caiola, i Massimo Broggini. "Activity of Pan-Class I Isoform PI3K/mTOR Inhibitor PF-05212384 in Combination With Crizotinib in Ovarian Cancer Xenografts and PDX()." Transl Oncol 2016.
Styl cytowania MLAIezzi, Alice, Elisa Caiola, i Massimo Broggini. "Activity of Pan-Class I Isoform PI3K/mTOR Inhibitor PF-05212384 in Combination With Crizotinib in Ovarian Cancer Xenografts and PDX()." Transl Oncol 2016.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..